Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Cytokinetics' CK-2127107 named FDA orphan drug for SMA

May 16, 2017

Seikagaku and Ono enter codevelopment and marketing collaboration on SI-613

May 15, 2017

FLX-787 demonstrates clinical benefit for treating nocturnal leg cramping

May 5, 2017

FDA accepts for review Xeljanz sNDAs for psoriatic arthritis

May 4, 2017

GlaxoSmithKline divulges BRD4 inhibitors

May 2, 2017

Trial finds urolithin A safe in healthy elderly subjects

May 2, 2017

Kyowa Hakko Kirin initiates global phase III trial of brodalumab in axial spondyloarthritis

April 26, 2017

EMA committee recommends E.U. approval of Kevzara

April 24, 2017

AbbVie conducting second phase III study of ABT-494 in psoriatic arthritis

April 24, 2017

FDA approves infliximab biosimilar Renflexis

April 24, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...